富祥药业：关于变更持续督导保荐代表人的公告

Core Points - Fuxiang Pharmaceutical announced a change in the representative responsible for ongoing supervision from the sponsor institution, Changjiang Securities [2] - The ongoing supervision period for the fundraising project initiated in 2020 will end on December 31, 2023, but due to unutilized funds, Changjiang Securities will continue its supervisory responsibilities [2] - The new representative, Zhang Ruipeng, will replace Wang Haitao, who is stepping down due to personal work adjustments [2]